Author： Deshpande S.S. Sheridan R.E. Adler M.
Publisher： Elsevier
ISSN： 0041-0101
Source： Toxicon, Vol.33, Iss.4, 1995-04, pp. : 551-557
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Development of recombinant vaccines for botulinum neurotoxin
By Smith L.A.
Toxicon, Vol. 36, Iss. 11, 1998-11 ,pp. :
By Mancin A.C. Soares A.M. Andriao-Escarso S.H. Faca V.M. Greene L.J. Zuccolotto S. Pela I.R. Giglio J.R.
Toxicon, Vol. 36, Iss. 12, 1998-12 ,pp. :
Separation of the components of type A botulinum neurotoxin complex by electrophoresis
By Sharma S.K. Ramzan M.A. Singh B.R.
Toxicon, Vol. 41, Iss. 3, 2003-03 ,pp. :
Genetic organization of the botulinum neurotoxin complex C1.
By Marvaud J.C. Hauser D. Gilbert M. Boquet P. Eklund M.W. Popoff M.R.
Toxicon, Vol. 34, Iss. 10, 1996-10 ,pp. :